A Stratified Sickle Event Randomized Trial (ASSERT)

PHASE3TerminatedINTERVENTIONAL
Enrollment

297

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

June 30, 2007

Conditions
Sickle Cell Disease
Interventions
DRUG

ICA-17043

Trial Locations (49)

Unknown

Mobile

Little Rock

Davis

Los Angeles

Oakland

Denver

Hartford

Washington D.C.

Holly Hill

Hollywood

Jacksonville

Augusta

Savannah

Chicago

Iowa City

New Orleans

Shreveport

Baltimore

Boston

Detroit

Jackson

Kansas City

Las Vegas

Hackensack

New Brunswick

Newark

Brooklyn

The Bronx

Chapel Hill

Durham

Greenville

Winston-Salem

Cincinnati

Cleveland

Philadelphia

Pittsburgh

Charleston

Memphis

Nashville

Houston

San Antonio

Richmond

Porto Alegre

Rio de Janeiro

São Paulo

Créteil

Kingston

Port of Spain

London

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

Icagen

INDUSTRY